Wilms Tumour (WT) is a paediatric renal tumour. Identifying necrosis in WT is clinically important; it can assess patients’ chemotherapy response and ultimately predict progression-free survival. It is also important for guiding biopsies. Lack of enhancement following intravenous administration of gadolinium is commonly used to identify necrosis, however, WT is a kidney tumour, and the use of gadolinium is contra-indicated in patients with renal failure. In this study we demonstrate how apparent diffusion coefficient values from DWI and pre-gad T1 imaging can predict the level of enhancement in WT, and quantify the percentage of necrotic tissue without exogenous contrast agents.
This abstract and the presentation materials are available to members only; a login is required.